Osaka, Japan

Susumu Hara

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Susumu Hara: Innovator in Corneal Endothelial Cell Research

Introduction

Susumu Hara is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of corneal endothelial cell research, holding a total of 3 patents. His work focuses on identifying and producing cell populations suitable for transplantation into the cornea, which is crucial for treating various eye conditions.

Latest Patents

Hara's latest patents include innovative methods and markers for corneal endothelial cells. One of his patents, titled "Corneal endothelial cell marker and use thereof," provides a means for identifying cells suitable for transplantation into a cornea. This patent outlines a method for producing a cell population suitable for transplantation, which involves preparing a cell population cultured under specific conditions and measuring the expression of genes such as POU6F2, LMX1B, and TFAP2B. Another patent focuses on a molecular marker expressed specifically in corneal endothelial cells, offering methods for producing and evaluating these cells using the identified markers, including ZP4, MRGPRX3, GRIP1, GLP1R, HTR1D, and CLRN1.

Career Highlights

Hara is affiliated with Osaka University, where he conducts his research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to advancements in regenerative medicine and cell therapy.

Collaborations

Hara collaborates with notable colleagues, including Kohji Nishida and Motokazu Tsujikawa. Their combined expertise enhances the research efforts in the field of corneal endothelial cell applications.

Conclusion

Susumu Hara's contributions to corneal endothelial cell research are invaluable, as they pave the way for future advancements in eye transplantation and regenerative medicine. His innovative patents and collaborations highlight his commitment to improving patient outcomes in ophthalmology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…